Opus Genetics, Inc. CEO sells $110,184 in IRD shares on the open market
The CEO sold at an average of $3.90 a share, according to a Form 4 filed with the SEC on Nov 5.
George Magrath, a chief executive officer of Opus Genetics, Inc. (IRD), sold 28,258 shares on Nov 3 at an average price of $3.90, a total of $110,184, according to a Form 4 filed with the SEC on Nov 5.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 2,010,636 shares held. Three Opus Genetics, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Opus Genetics, Inc. (IRD) |
|---|---|
| Insider | George Magrath |
| Role | CEO |
| Transaction | Open-market sale (code S) |
| Shares | 28,258 |
| Average price | $3.90 |
| Value | $110,184 |
| Trade date | Nov 3, 2026 |
| Filed with the SEC | Nov 5, 2026, 4:04 PM ET |
| Shares held after | 2,010,636 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
Open the full breakdown of this IRD trade
See all insider activity at Opus Genetics, Inc. · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.